Search - tctmd.com

Displaying 201 - 220 of 892

Sort: Relevancy | Date

Top General Cardiology and Prevention News of 2022

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke

News Daily News

Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke

December 21, 2022

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

December 16, 2022

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

News Daily News

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

December 06, 2022

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

November 21, 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

News Conference News AHA 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

November 10, 2022

RAPCO: Radial Artery Beats of Both RITA and Vein Grafting at 15 Years

News Conference News AHA 2022

RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years

Yael L. Maxwell

November 06, 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

Michael O'Riordan

October 28, 2022

Early Data Suggest Plant-Based Foods Could Improve Outcomes in HF

News Daily News

Early Data Suggest Plant-Based Foods Could Improve Outcomes in HF

October 26, 2022

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

News Daily News

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

October 26, 2022

New Biomarker-Based Risk Score Performs Well in ACS

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

September 23, 2022

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

News Conference News TCT 2022

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

September 17, 2022

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.